| Margaux Noble Mustian, MD | |
|
625 19th St S, Birmingham, AL 35233-1900 | |
| (205) 934-3065 | |
| Not Available |
| Full Name | Margaux Noble Mustian |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 10 Years |
| Location | 625 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710306485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD.34766 (Alabama) | Primary |
| 208600000X | Surgery | 34766 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Insulet Corporation, the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG (SIX Swiss Exchange: YPSN), a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announced an exclusive agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, as well as China and Australia.
As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.
For Medicaid enrollees with mental health disorders, losing Medicaid coverage leads to lasting reductions in overall healthcare use, and in outpatient mental health treatment specifically, reports a study in the July issue of Medical Care.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
› Verified 5 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Insulet Corporation, the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG (SIX Swiss Exchange: YPSN), a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announced an exclusive agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, as well as China and Australia.
As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.
For Medicaid enrollees with mental health disorders, losing Medicaid coverage leads to lasting reductions in overall healthcare use, and in outpatient mental health treatment specifically, reports a study in the July issue of Medical Care.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
› Verified 5 days ago
| Entity Name | The Russell Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417252537 PECOS PAC ID: 6406754431 Enrollment ID: O20110307000502 |
News Archive
Insulet Corporation, the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG (SIX Swiss Exchange: YPSN), a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announced an exclusive agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, as well as China and Australia.
As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.
For Medicaid enrollees with mental health disorders, losing Medicaid coverage leads to lasting reductions in overall healthcare use, and in outpatient mental health treatment specifically, reports a study in the July issue of Medical Care.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
› Verified 5 days ago
| Entity Name | Nwmc Winfield Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366831380 PECOS PAC ID: 8921324393 Enrollment ID: O20150302000951 |
News Archive
Insulet Corporation, the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG (SIX Swiss Exchange: YPSN), a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announced an exclusive agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, as well as China and Australia.
As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.
For Medicaid enrollees with mental health disorders, losing Medicaid coverage leads to lasting reductions in overall healthcare use, and in outpatient mental health treatment specifically, reports a study in the July issue of Medical Care.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Margaux Noble Mustian, MD 625 19th St S, Birmingham, AL 35233-1900 Ph: () - | Margaux Noble Mustian, MD 625 19th St S, Birmingham, AL 35233-1900 Ph: (205) 934-3065 |
News Archive
Insulet Corporation, the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG (SIX Swiss Exchange: YPSN), a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announced an exclusive agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, as well as China and Australia.
As children made fewer visits to health facilities and engaged in social distancing and other COVID-19 mitigation measures, a smaller number of them also received prescription drugs, a new study suggests.
For Medicaid enrollees with mental health disorders, losing Medicaid coverage leads to lasting reductions in overall healthcare use, and in outpatient mental health treatment specifically, reports a study in the July issue of Medical Care.
GlaxoSmithKline (GSK) today announced that the Company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at increased risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
› Verified 5 days ago
Melanie Morris, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Rebecca Horst, PA Surgery Medicare: Medicare Enrolled Practice Location: 817 Princeton Ave Sw Ste 306, Birmingham, AL 35211 Phone: 205-783-0160 Fax: 205-788-6249 | |
Timothy Lee Christopher, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 400, Birmingham, AL 35243 Phone: 205-595-8985 Fax: 205-595-8987 | |
Dr. Richard Ira Kirkland, MD Surgery Medicare: Medicare Enrolled Practice Location: 513 Brookwood Blvd, Suite 501, Birmingham, AL 35209 Phone: 205-930-8010 Fax: 205-930-8014 | |
Kyle Stigall, MD Surgery Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-4011 | |
Jayme Locke, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Emily Long, MD Surgery Medicare: Medicare Enrolled Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3000 |